195 related articles for article (PubMed ID: 15976496)
1. Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade.
Kasper SO; Basso N; Kurnjek ML; Paglia N; Ferrario CM; Ferder LF; Diz DI
Am J Nephrol; 2005; 25(4):335-41. PubMed ID: 15976496
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
4. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
5. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Mackie FE; Meyer TW; Campbell DJ
Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
[TBL] [Abstract][Full Text] [Related]
7. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
[TBL] [Abstract][Full Text] [Related]
8. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
[TBL] [Abstract][Full Text] [Related]
9. Direct renin inhibition in a rat model of chronic allograft injury.
Rusai K; Schmaderer C; Hermans JJ; Lutz J; Heemann U; Baumann M
Transplantation; 2011 Nov; 92(9):999-1004. PubMed ID: 21956196
[TBL] [Abstract][Full Text] [Related]
10. Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.
Graciano ML; Cavaglieri Rde C; Dellê H; Dominguez WV; Casarini DE; Malheiros DM; Noronha IL
J Am Soc Nephrol; 2004 Jul; 15(7):1805-15. PubMed ID: 15213268
[TBL] [Abstract][Full Text] [Related]
11. Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system.
Inserra F; Basso N; Ferder M; Userpater M; Stella I; Paglia N; Inserra P; Tenembaum D; Ferder L
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):341-6. PubMed ID: 19574289
[TBL] [Abstract][Full Text] [Related]
12. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
Guo X; Wang J; Elimban V; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
[TBL] [Abstract][Full Text] [Related]
13. Renin angiotensin system blockade ameliorates lead nephropathy.
Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
[TBL] [Abstract][Full Text] [Related]
14. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
Gündüz F; Kuru O; Sentürk UK
Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
18. Combination effects of enalapril and losartan on lipid peroxidation in the kidneys of KK-Ay/Ta mice.
Yamazaki T; Tanimoto M; Gohda T; Ohara I; Hagiwara S; Murakoshi M; Matsumoto M; Kaneko S; Aoki T; Toyoda H; Ishikawa Y; Funabiki K; Horikoshi S; Tomino Y
Nephron Exp Nephrol; 2009; 113(2):e66-76. PubMed ID: 19609084
[TBL] [Abstract][Full Text] [Related]
19. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
Demeilliers B; Jover B; Mimran A
J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of long-term angiotensin II inhibition.
Basso N; Cini R; Pietrelli A; Ferder L; Terragno NA; Inserra F
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1351-8. PubMed ID: 17557916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
